Loading…
Rafa Laboratories Ltd. was awarded a follow-on production agreement valued at over $45 million from the U.S. Department of Defense's JPEO-CBRND for the Midazolam Injection autoinjector (Advanced Anticonvulsant System). Deliveries began in December 2022.